Entia
Latest round
- Series A
Last raised
- Jul 2023
Total raised
- $39M
Investors
- 4
About Entia
, based in the UK, specializes in at-home blood monitoring solutions, empowering patients to perform their own blood tests.Founded in 2014 and headquartered in London, UK, Entia Ltd. offers advanced blood monitoring solutions for home use.Entia's primary offering is the Liberty at-home blood monitoring solution, the first of its kind designed for patients to perform their own blood tests from home. This innovative system enables users to conduct tests related to blood counts, liver function, kidney function, electrolytes, and immune markers, thereby streamlining the process of routine health assessments and promoting proactive care. The simplicity of the tests allows patients to gain insights into their health status, ultimately facilitating personalized and preventative care pathways within communities. Liberty integrates seamlessly with existing clinical practices and patient support programs, and it is interoperable with various digital health solutions, enhancing its utility.Entia's revenue model centers around the sale of its flagship product, the Liberty blood monitoring system, directly to consumers and healthcare providers. Transactions typically occur through a combination of direct-to-consumer sales and partnerships with healthcare institutions that incorporate the testing solutions into their patient care programs. The company establishes pricing plans which are structured to cater to both individual consumers and healthcare providers, facilitating accessibility for a diverse client base. By focusing on a subscription model for ongoing support and testing supplies, along with potential partnerships with pharmaceutical companies for integrated healthcare solutions, Entia positions itself for sustainable revenue generation.In July 2023, Entia Ltd. The company is focused on expanding into new geographic regions, with specific plans to penetrate the US market by facilitating access to its innovative blood monitoring solutions.
Who invested in Entia
4 investors across 4 rounds
See all investors in Entia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Entia
Who invested in Entia?
Entia has 4 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Entia raised?
Entia has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Entia last raise money?
Entia's most recent round on record is a Series A, in Jul 2023.
What does Entia do?
, based in the UK, specializes in at-home blood monitoring solutions, empowering patients to perform their own blood tests.
Where is Entia headquartered?
Entia is headquartered in London, UK.
Which VCs invest in companies like Entia?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at Entia's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Entia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.